// App-Quantinova.ai

TCTAP A-167 : Bioabsorbable Vascular Scaffolds (BVS) Eluting with Everolimus: for Percutaneous Coronary Intervention (PCI) of Patients with De-novo Coronary Artery Lesion: Our Experiences at Apollo Hospitals Dhaka

Researchers

Presenter

  • Shams Munwar

Principal Investigators

  • AHM Waliul Islam

  • Shahbudin Talukder

  • A.Q.M. Reza

  • Tamzeed Ahmed

  • Azfar H. Bhuiyan

  • Rowsan Masud

  • Atique B. Siddique

Medical Centers

  • Apollo Hospitals, Dhaka, Bangladesh

Locations

  • Bangladesh

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetes

  • Dyslipidemia

  • Venous thrombosis

Biomarkers

  • Body mass index

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved